Literature DB >> 2220914

Contraception and ectopic pregnancy risk.

A L Franks1, V Beral, W Cates, C J Hogue.   

Abstract

Studies of the association of ectopic pregnancy with contraception have generated a conflicting array of results because of methodologic differences between studies. We estimated the absolute incidence rates of ectopic pregnancy for various contraceptives by multiplying the pregnancy rate by the proportion of pregnancies with ectopic implantation for each method. Our results indicated a more than 500-fold difference in ectopic pregnancy incidence, from a low of 0.005 ectopic pregnancies per 1000 women years of oral contraception or vasectomy to a high of 2.6 per 1000 women years of no contraception. These estimated incidence rates should be useful for clinicians and patients seeking to better understand the risks and benefits of contraceptives.

Entities:  

Keywords:  Americas; Barrier Methods; Condom; Contraception; Contraceptive Methods; Demographic Factors; Developed Countries; Diseases; Family Planning; Female Sterilization; Fertility; Fertility Measurements; High Risk Women; Incidence; Iud; Male Sterilization; Measurement; North America; Northern America; Population; Population Dynamics; Pregnancy Complications; Pregnancy Rate; Pregnancy, Ectopic; Reproduction; Research Methodology; Research Report; Statistical Studies; Sterilization, Sexual; Studies; United States; Vasectomy

Mesh:

Substances:

Year:  1990        PMID: 2220914     DOI: 10.1016/0002-9378(90)90668-w

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

Review 1.  Noncontraceptive health benefits of oral contraceptives.

Authors:  Andrew M Kaunitz
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

2.  Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis.

Authors:  M Egger; N Low; G D Smith; B Lindblom; B Herrmann
Journal:  BMJ       Date:  1998-06-13

Review 3.  A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.

Authors:  F Sturridge; J Guillebaud
Journal:  Drug Saf       Date:  1996-12       Impact factor: 5.606

4.  Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.

Authors:  Tiina Backman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.